EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hvass, U.
Right arrow Articles by Lenormand, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hvass, U.
Right arrow Articles by Lenormand, C.

European Journal of Cardio-Thoracic Surgery, Vol 8, 384-387, Copyright © 1994 by European Association for Cardio-thoracic Surgery


ARTICLES

The O'Brien-Angell stentless valve. Early results of 100 implants

U Hvass, D Chatel, M Ouroudji, Y Pansard, T Laperche, JP Depoix and C Lenormand
Hopital Bichat, Chirurgie Cardio Vasculaire, Paris, France.

From August 1991 to May 1993, 100 unselected consecutive patients in whom an aortic bioprosthesis was indicated underwent aortic valve replacement with the O'Brien-Angell stentless porcine xenograft (Bravo Cardiovascular Model 300). The indication was calcified aortic stenosis (AS) in 62 cases (isolated in 44, with associated cardiac lesions in 18), aortic insufficiency in 24 cases (isolated in 13 with associated cardiac lesions in 11), and redo operations in 14 cases. Forty-four percent of the patients were over 70 years of age. With the recommended supra-annular single running suture technique, the aortic cross-clamp times in isolated procedures ranged from 32 to 70 min, mean 39 min. Valve function was studied by echocardiography in 92 patients. Early post-operative transvalvular gradients were usually in the low range, below 15 mmHg in 68% of the cases. Isolated central valvular regurgitation was absent in 60.8%, "microscopic to trivial in 31.5% and mild to moderate in 1.2%. Perivalvular regurgitation was absent in 65.2%, microscopic to trivial in 26.2% and mild to moderate in 3.2%. Thirty-five of 40 patients with follow-ups exceeding 6 months had non- invasive controls. Transvalvular gradients showed a 30 to 40% reduction when compared to the immediate postoperative values. There were no new isolated central regurgitations but in two cases previously mild-to- moderate perivalvular leaks evolved to moderately severe leaks. Two valves were explanted, one for rupture of a Prolene 4/0 and one due to a slack Prolene 4/0 suture. We consider that the O'Brien-Angell stentless valve was easy to handle in all situations encountered.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. Bertolini, G. B. Luciani, B. Vecchi, P. Pugliese, and A. Mazzucco
Aortic valve replacement with the biocor PSB stentless xenograft
Ann. Thorac. Surg., August 1, 1998; 66(2): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. B. Luciani, P. Bertolini, and A. Mazzucco
Early failure of freehand aortic stentless xenograft valves
J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 963 - 964.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
N. D. Kon, S. Westaby, N. Amarasena, R. Pillai, and A. R. Cordell
Comparison of Implantation Techniques Using Freestyle Stentless Porcine Aortic Valve
Ann. Thorac. Surg., April 1, 1995; 59(4): 857 - 862.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.